Albert P. Parker
2020
In 2020, Albert P. Parker earned a total compensation of $1.4M as Chief Operating Officer at Oncocyte Corp, a 54% increase compared to previous year.
Compensation breakdown
| Bonus | $133,465 |
|---|---|
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,082 |
| Option Awards | $530,363 |
| Salary | $348,948 |
| Other | $386,135 |
| Total | $1,399,993 |
Parker received $530.4K in option awards, accounting for 38% of the total pay in 2020.
Parker also received $133.5K in bonus, $1.1K of change in pension value and nonqualified deferred compensation earnings, $348.9K in salary and $386.1K in other compensation.
Rankings
In 2020, Albert P. Parker's compensation ranked 7,150th out of 13,090 executives tracked by ExecPay. In other words, Parker earned more than 45.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,150 out of 13,090 | 45th |
Division Manufacturing | 2,988 out of 5,620 | 47th |
Major group Chemicals And Allied Products | 1,206 out of 2,253 | 47th |
Industry group Drugs | 1,039 out of 1,953 | 47th |
Industry In Vitro and In Vivo Diagnostic Substances | 17 out of 60 | 72nd |
Source: SEC filing on May 21, 2021.
Parker's colleagues
We found three more compensation records of executives who worked with Albert P. Parker at Oncocyte Corp in 2020.